A RAPID FLUORESCENCE BASED SCREEN FOR CYP51 INHIBITION

被引：0
|
作者：
Voice, Michael [1 ]
Macintyre, Gillian [1 ]
Pritchard, Michael [1 ]
机构：
[1] Cypex Ltd, Dundee, Scotland
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2020年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P26
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [1] Structure Based Design of CYP51 Inhibitors
    Choi, Jun Yong
    Roush, William R.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (01) : 30 - 39
  • [2] Structural Basis of Human CYP51 Inhibition by Antifungal Azoles
    Strushkevich, Natallia
    Usanov, Sergey A.
    Park, Hee-Won
    JOURNAL OF MOLECULAR BIOLOGY, 2010, 397 (04) : 1067 - 1078
  • [3] Biodiversity of CYP51 in trypanosomes
    Lepesheva, G. I.
    Hargrove, T. Y.
    Ott, R. D.
    Nes, W. D.
    Waterman, M. R.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2006, 34 : 1161 - 1164
  • [4] CYP51: Is it a Good Idea?
    Sueth-Santiago, Vitor
    Franklim, Tatiany N.
    Lopes, Natalia D.
    de Lima, Marco Edilson F.
    REVISTA VIRTUAL DE QUIMICA, 2015, 7 (02) : 539 - 575
  • [5] Differential inhibition of Candida albicans CYP51 with azole antifungal stereoisomers
    Lamb, DC
    Kelly, DE
    Baldwin, BC
    Gozzo, F
    Boscott, P
    Richards, WG
    Kelly, SL
    FEMS MICROBIOLOGY LETTERS, 1997, 149 (01) : 25 - 30
  • [6] CYP51: A Target for Drug Design
    Waterman, Michael R.
    Lepesheva, Galina I.
    DRUG METABOLISM REVIEWS, 2010, 42 : 17 - 17
  • [7] The Role of CYP51 in Global Health
    Waterman, Michael R.
    Lepeshesheva, Galina I.
    DRUG METABOLISM REVIEWS, 2010, 42 : 130 - 130
  • [8] CYP51 inhibitors for Chagas disease
    Lepesheva, Galina
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [9] Trypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen Hit
    Chen, Chiung-Kuang
    Doyle, Patricia S.
    Yermalitskaya, Liudmila V.
    Mackey, Zachary B.
    Ang, Kenny K. H.
    McKerrow, James H.
    Podust, Larissa M.
    PLOS NEGLECTED TROPICAL DISEASES, 2009, 3 (02):
  • [10] Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease
    Riley, Jennifer
    Brand, Stephen
    Voice, Michael
    Caballero, Ivan
    Calvo, David
    Read, Kevin D.
    PLOS NEGLECTED TROPICAL DISEASES, 2015, 9 (09):
12345